|
2025
|
Invention
|
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modification... |
|
2024
|
Invention
|
Methods for producing triterpenoid derivatives. In some aspects, the present disclosure provides ... |
|
|
Invention
|
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use ... |
|
|
Invention
|
Methods of treating obesity using antioxidant inflammation modulators.
The present invention rel... |
|
2023
|
Invention
|
Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs th... |
|
2021
|
Invention
|
Methods of administering synthetic triterpenoids.
Provided are methods of administering syntheti... |
|
|
Invention
|
Methods of treating covid-19 using bardoxolone methyl or analogs thereof.
The present invention ... |
|
|
Invention
|
Methods of treating covid-19 using bardoxolone methyl or analogs thereof. The present invention p... |
|
|
Invention
|
Methods of treating alport syndrome using bardoxolone methyl or analogs thereof. The present inve... |
|
2018
|
Invention
|
Methods of treating obesity using antioxidant inflammation modulators. The present invention rela... |
|
2017
|
Invention
|
Synthetic triterpenoids and methods of use in the treatment of disease.
The present invention co... |
|
|
Invention
|
Antioxidant inflamation modulators: oleanolic acid derivatives with amino and other modifications... |
|
2014
|
Invention
|
Methods of treating and preventing renal disease using bardoxolone methyl or analogs thereof. The... |
|
|
Invention
|
Delayed release, oral dosage compositions that contain amorphous cddo-me. Pharmaceutical formulat... |
|
2013
|
Invention
|
Synthetic triterpenoids and methods of use in the treatment of disease. The present invention con... |
|
2012
|
Invention
|
Forms of cddo methyl ester. A triterpenoid compound, methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-... |
|
|
Invention
|
Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modific... |
|
2010
|
Invention
|
Delayed release, oral dosage compositions that contain amorphous cddo-me.
Pharmaceuti... |
|
2009
|
Invention
|
Synthetic triterpenoids and methods of use in the treatment of disease.
The present in... |
|
2008
|
Invention
|
Novel forms of cddo methyl ester.
A triterpenoid compound, methyl 2-cyano-3,12-dioxole... |
